[Form 4] CAVA Group, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Form 4 overview: CAVA Group, Inc. (ticker: CAVA) disclosed an insider equity transaction involving director Benjamin Felt on 20 June 2025. The filing reports the grant of 1,767 restricted stock units (RSUs) to Felt, coded “A” (acquisition) at a price of $0, reflecting standard equity compensation rather than an open-market purchase. Following the grant, Felt’s total beneficial ownership stands at 8,074 common shares, a figure that includes unvested RSUs.

Vesting terms: The RSUs vest in full on the earlier of (i) 20 June 2026 or (ii) the business day preceding the next annual shareholders’ meeting, contingent upon Felt’s continued board service. Each vested RSU converts into one share of CAVA common stock.

Investor relevance: The transaction is routine director compensation and involves a relatively small number of shares, implying de-minimis dilution and limited market impact. Nevertheless, it modestly aligns director incentives with shareholder interests by increasing direct equity exposure.

Insights

Securities Analyst

TL;DR: Routine RSU grant; negligible dilution, neutral impact.

Director Benjamin Felt received 1,767 RSUs, lifting ownership to 8,074 shares. The award vests in roughly one year or earlier if the next AGM comes first. Such grants are customary for board compensation and do not signal insider sentiment or operational change. Share count impact is immaterial relative to CAVA’s outstanding shares, so I view the filing as informational with neutral valuation effect.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Felt Benjamin

(Last) (First) (Middle)

C/O CAVA GROUP, INC.

14 RIDGE SQUARE NW, SUITE 500

(Street)

WASHINGTON DC 20016

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CAVA GROUP, INC. [ CAVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/20/2025		A(1)		1,767	A	$0	8,074(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a grant of restricted stock units ("RSU"), which vest in full on the earlier of (i) June 20, 2026 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the "Issuer"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement.

2. Includes unvested RSUs.

Remarks:

	/s/ Kenneth Robert Bertram, as Attorney-in-Fact	06/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares did CAVA director Benjamin Felt acquire in the latest Form 4?

He was granted 1,767 restricted stock units, each convertible into one common share upon vesting.

What is Benjamin Felt’s total beneficial ownership in CAVA after the grant?

After the transaction, Felt beneficially owns 8,074 shares (including unvested RSUs).

When do the newly granted CAVA RSUs vest?

The RSUs vest in full on the earlier of 20 June 2026 or the business day before CAVA’s next annual shareholder meeting.

Did the director pay anything for the RSU grant?

No. The RSUs were granted at $0 cost as part of standard board compensation.

Is this Form 4 filing considered material for CAVA investors?

Given the small share amount relative to CAVA’s float, most analysts view the filing as routine and not materially impactful.